Intraocular lens power calculation after laser in situ keratomileusis for myopia and hyperopia: a standardized approach.

PubWeight™: 1.90‹?› | Rank: Top 3%

🔗 View Article (PMID 11685053)

Published in Cornea on November 01, 2001

Authors

V Feiz1, M J Mannis, F Garcia-Ferrer, G Kandavel, J K Darlington, E Kim, J Caspar, J L Wang, W Wang

Author Affiliations

1: Department of Ophthalmology, University of Arkansas for Medical Science, USA.

Articles citing this

An intraocular lens power calculation formula based on optical coherence tomography: a pilot study. J Refract Surg (2010) 1.07

Intraocular lens power calculation following laser refractive surgery. Eye Vis (Lond) (2015) 0.94

Optical coherence tomography-based corneal power measurement and intraocular lens power calculation following laser vision correction (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc (2013) 0.84

Comparison of intraocular lens power calculation methods in eyes that have undergone laser-assisted in-situ keratomileusis. Trans Am Ophthalmol Soc (2004) 0.84

Comparison of Newer Intraocular Lens Power Calculation Methods for Eyes after Corneal Refractive Surgery. Ophthalmology (2015) 0.83

Ray tracing software for intraocular lens power calculation after corneal excimer laser surgery. Jpn J Ophthalmol (2014) 0.81

Intraocular lens power calculation after corneal refractive surgery. Middle East Afr J Ophthalmol (2010) 0.81

IOLMaster versus Manual Keratometry after Photorefractive Keratectomy. J Ophthalmic Vis Res (2011) 0.80

Personalized pseudophakic model for refractive assessment. PLoS One (2012) 0.80

Evaluation of the American Society of Cataract and Refractive Surgery intraocular lens calculator for eyes with prior radial keratotomy. Clin Ophthalmol (2011) 0.79

IOL power calculation after corneal refractive surgery. Biomed Res Int (2014) 0.77

The comparison of central and mean true-net power (Pentacam) in calculating IOL-power after refractive surgery. Korean J Ophthalmol (2009) 0.77

Intraocular lens power calculation after corneal refractive surgery. J Ophthalmic Vis Res (2012) 0.76

A comparison of the American Society of Cataract and Refractive Surgery post-myopic LASI K/PRK intraocular lens (IOL) calculator and the Ocular MD IOL calculator. Clin Ophthalmol (2011) 0.76

Orbscan II and double-K method for IOL calculation after refractive surgery. Graefes Arch Clin Exp Ophthalmol (2012) 0.76

Estimation of intraocular lens power calculation after myopic corneal refractive surgery: using corneal height in anterior segment optical coherence tomography. Korean J Ophthalmol (2015) 0.75

Orbscan II-assisted intraocular lens power calculation for cataract surgery following myopic laser in situ keratomileusis (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc (2006) 0.75

Intraocular lens power calculation after laser in situ keratomileusis and retinal detachment repair. Cornea (2003) 0.75

Comparison of Newer IOL Power Calculation Methods for Eyes With Previous Radial Keratotomy. Invest Ophthalmol Vis Sci (2016) 0.75

Comparison of the accuracy of intraocular lens power calculations for cataract surgery in eyes after phototherapeutic keratectomy. Jpn J Ophthalmol (2016) 0.75

Predictability of Sirius dual-scanning corneal tomography in the measurement of corneal power after photorefractive surgery. Int Ophthalmol (2015) 0.75

Articles by these authors

Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. Acc Chem Res (2000) 10.78

A new class of membrane-bound chemokine with a CX3C motif. Nature (1997) 7.87

NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities. Mol Cell (1998) 7.58

Negative feedback regulation of TGF-beta signaling by the SnoN oncoprotein. Science (1999) 7.51

Crystal structures of a complexed and peptide-free membrane protein-binding domain: molecular basis of peptide recognition by PDZ. Cell (1996) 6.87

RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell (1995) 5.73

Binding and stimulation of HIV-1 integrase by a human homolog of yeast transcription factor SNF5. Science (1994) 5.47

Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens. Nature (2011) 5.41

Rapid evolution of male reproductive genes in the descent of man. Nature (2000) 5.33

Identifying tumor suppressors in genetic mosaics: the Drosophila lats gene encodes a putative protein kinase. Development (1995) 5.18

Receptor mobility and receptor-cytoplasmic interactions in lymphocytes. Proc Natl Acad Sci U S A (1973) 5.13

Rapid and phosphoinositol-dependent binding of the SWI/SNF-like BAF complex to chromatin after T lymphocyte receptor signaling. Cell (1998) 4.95

Concanavalin A derivatives with altered biological activities. Proc Natl Acad Sci U S A (1973) 4.75

Shank, a novel family of postsynaptic density proteins that binds to the NMDA receptor/PSD-95/GKAP complex and cortactin. Neuron (1999) 4.59

Emerging tobacco hazards in China: 2. Early mortality results from a prospective study. BMJ (1998) 4.51

Bone development. Annu Rev Cell Dev Biol (2000) 4.24

Evolution of digital organisms at high mutation rates leads to survival of the flattest. Nature (2001) 3.92

Interaction between the C terminus of NMDA receptor subunits and multiple members of the PSD-95 family of membrane-associated guanylate kinases. J Neurosci (1996) 3.64

Zeta phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists. Science (1995) 3.40

Regulation of dendritic spine morphology by SPAR, a PSD-95-associated RapGAP. Neuron (2001) 3.30

The human SWI/SNF-B chromatin-remodeling complex is related to yeast rsc and localizes at kinetochores of mitotic chromosomes. Proc Natl Acad Sci U S A (2000) 3.16

Hazard rate estimation under random censoring with varying kernels and bandwidths. Biometrics (1994) 3.12

The Shank family of scaffold proteins. J Cell Sci (2000) 3.11

The covalent and three-dimensional structure of concanavalin A. Proc Natl Acad Sci U S A (1972) 3.09

Homo- and heterodimeric interactions between the gene products of PKD1 and PKD2. Proc Natl Acad Sci U S A (1997) 3.06

Use of radiolabeled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photoscanning. N Engl J Med (1978) 3.00

BRCA1 is associated with a human SWI/SNF-related complex: linking chromatin remodeling to breast cancer. Cell (2000) 2.94

Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes (1992) 2.92

Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet (2000) 2.82

NMDA receptors mediate calcium accumulation in myelin during chemical ischaemia. Nature (2005) 2.74

Processing of the notch ligand delta by the metalloprotease Kuzbanian. Science (1999) 2.71

Paternal population history of East Asia: sources, patterns, and microevolutionary processes. Am J Hum Genet (2001) 2.71

A specificity and targeting subunit of a human SWI/SNF family-related chromatin-remodeling complex. Mol Cell Biol (2000) 2.70

Ribosomal protein S7 as a novel modulator of p53-MDM2 interaction: binding to MDM2, stabilization of p53 protein, and activation of p53 function. Oncogene (2007) 2.68

The intermediate endpoint effect in logistic and probit regression. Clin Trials (2007) 2.67

Mre11 protein complex prevents double-strand break accumulation during chromosomal DNA replication. Mol Cell (2001) 2.65

Unusual fragments in the subunit structure of concanavalin A. Proc Natl Acad Sci U S A (1971) 2.62

Type 1 protein phosphatase acts in opposition to IpL1 protein kinase in regulating yeast chromosome segregation. Mol Cell Biol (1994) 2.59

Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I/II trial. Pediatric Hydroxyurea Group. Blood (1999) 2.59

Atrial G protein-activated K+ channel: expression cloning and molecular properties. Proc Natl Acad Sci U S A (1993) 2.57

Sino-MONICA project: a collaborative study on trends and determinants in cardiovascular diseases in China, Part i: morbidity and mortality monitoring. Circulation (2001) 2.56

The complete amino acid sequence of beta 2-microglobulin. Biochemistry (1973) 2.55

Use of MM-PBSA in reproducing the binding free energies to HIV-1 RT of TIBO derivatives and predicting the binding mode to HIV-1 RT of efavirenz by docking and MM-PBSA. J Am Chem Soc (2001) 2.55

Hormonal changes in the grains of rice subjected to water stress during grain filling. Plant Physiol (2001) 2.52

The Ski oncoprotein interacts with the Smad proteins to repress TGFbeta signaling. Genes Dev (1999) 2.52

Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmacol Ther (2001) 2.51

Heterogeneity in the molecular composition of excitatory postsynaptic sites during development of hippocampal neurons in culture. J Neurosci (1998) 2.48

Genetic influence on the structural variations of the abnormal prion protein. Proc Natl Acad Sci U S A (2000) 2.46

All-cause mortality and cardiovascular disease mortality in three American Indian populations, aged 45-74 years, 1984-1988. The Strong Heart Study. Am J Epidemiol (1998) 2.43

Biomarker risk assessment and bladder cancer detection in a cohort exposed to benzidine. J Natl Cancer Inst (2001) 2.41

Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease. Blood (1990) 2.38

Pattern of marine mass extinction near the Permian-Triassic boundary in South China. Science (2000) 2.38

De novo amyloid proteins from designed combinatorial libraries. Proc Natl Acad Sci U S A (1999) 2.38

Predicting caries in permanent teeth from caries in primary teeth: an eight-year cohort study. J Dent Res (2002) 2.35

The kinetics of cellular commitment during stimulation of lymphocytes by lectins. J Cell Biol (1974) 2.33

ATPase activity of the cystic fibrosis transmembrane conductance regulator. J Biol Chem (1996) 2.33

A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Blood (1993) 2.29

Regulation of Ca2+ signaling in transgenic mouse cardiac myocytes overexpressing calsequestrin. J Clin Invest (1998) 2.29

Dynamic relocation of transcription and splicing factors dependent upon transcriptional activity. EMBO J (1997) 2.27

A family of chromatin remodeling factors related to Williams syndrome transcription factor. Proc Natl Acad Sci U S A (2000) 2.24

CCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3alpha and is highly expressed in human dendritic cells. J Exp Med (1997) 2.24

The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product. Proc Natl Acad Sci U S A (1996) 2.24

Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients. Angiotensin-converting Enzyme Inhibitor Myocardial Infarction Collaborative Group. J Am Coll Cardiol (2000) 2.22

TRAPP I implicated in the specificity of tethering in ER-to-Golgi transport. Mol Cell (2001) 2.20

Quality of life for children with fecal incontinence after surgically corrected anorectal malformation. J Pediatr Surg (2000) 2.17

Mortality and cardiovascular disease among older live kidney donors. Am J Transplant (2014) 2.16

The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma. Oncogene (2000) 2.15

Identification of galectin-3 as a factor in pre-mRNA splicing. Proc Natl Acad Sci U S A (1995) 2.11

A decamer duplication in the 3' region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindred. Proc Natl Acad Sci U S A (2000) 2.11

The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism. Science (1998) 2.11

Validity of the ten questions screened for childhood disability: results from population-based studies in Bangladesh, Jamaica, and Pakistan. Epidemiology (1994) 2.10

Hydration of fat-free body mass: new physiological modeling approach. Am J Physiol (1999) 2.09

Specific association of the gene product of PKD2 with the TRPC1 channel. Proc Natl Acad Sci U S A (1999) 2.09

Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146,958 pregnancies. Ultrasound Obstet Gynecol (2015) 2.07

Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans. Proc Natl Acad Sci U S A (1993) 2.06

Characterization of the Shank family of synaptic proteins. Multiple genes, alternative splicing, and differential expression in brain and development. J Biol Chem (1999) 2.03

Actinonin, a naturally occurring antibacterial agent, is a potent deformylase inhibitor. Biochemistry (2000) 2.03

Repeatability of the Pedar-X in-shoe pressure measuring system. Foot Ankle Surg (2009) 2.03

Characterization of SWI/SNF protein expression in human breast cancer cell lines and other malignancies. J Cell Physiol (2001) 2.02

Modulation of lymphocyte mitogenesis. Proc Natl Acad Sci U S A (1975) 2.02

Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart. Circulation (2000) 2.01

A frame shift mutation in the DNA-binding domain of the androgen receptor gene associated with complete androgen insensitivity, persistent müllerian structures, and germ cell tumors in dysgenetic gonads. Fertil Steril (1999) 2.00

Cognitive functioning and brain magnetic resonance imaging in children with sickle Cell disease. Neuropsychology Committee of the Cooperative Study of Sickle Cell Disease. Pediatrics (1996) 1.98

The regulation of glucose-excited neurons in the hypothalamic arcuate nucleus by glucose and feeding-relevant peptides. Diabetes (2004) 1.96

Cutting edge: the orphan chemokine receptor G protein-coupled receptor-2 (GPR-2, CCR10) binds the skin-associated chemokine CCL27 (CTACK/ALP/ILC). J Immunol (2000) 1.95

HEF1 is a necessary and specific downstream effector of FAK that promotes the migration of glioblastoma cells. Oncogene (2006) 1.94

The 3'-end-processing factor CPSF is required for the splicing of single-intron pre-mRNAs in vivo. RNA (2001) 1.94

Down-regulation of cyclin D1 expression by prostaglandin A(2) is mediated by enhanced cyclin D1 mRNA turnover. Mol Cell Biol (2000) 1.93

H36-alpha 7 is a novel integrin alpha chain that is developmentally regulated during skeletal myogenesis. J Cell Biol (1992) 1.89

Essential role for dlg in synaptic clustering of Shaker K+ channels in vivo. J Neurosci (1997) 1.88

Interaction of the postsynaptic density-95/guanylate kinase domain-associated protein complex with a light chain of myosin-V and dynein. J Neurosci (2000) 1.88

Curbing the nonsense: the activation and regulation of mRNA surveillance. Genes Dev (2001) 1.87

Breast-cancer diagnosis with nipple fluid bFGF. Lancet (2000) 1.86

Caspase and calpain activation both contribute to sepsis-induced diaphragmatic weakness. J Appl Physiol (1985) (2009) 1.86

Harvesting energy from the marine sediment--water interface. Environ Sci Technol (2001) 1.85

Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center. Ultrasound Obstet Gynecol (2014) 1.85

Chemical constituents from Dendrobium densiflorum. Phytochemistry (2001) 1.82

A computational approach to simplifying the protein folding alphabet. Nat Struct Biol (1999) 1.82

Interleukin 1 beta induces the formation of nitric oxide by beta-cells purified from rodent islets of Langerhans. Evidence for the beta-cell as a source and site of action of nitric oxide. J Clin Invest (1992) 1.82